Stockscreener 앱 받기
4.32
0.70%
0.03
시간 외 거래:
4.33
0.010
+0.23%
전일 마감가:
$4.29
열려 있는:
$4.26
하루 거래량:
434.43K
Relative Volume:
0.77
시가총액:
$90.65M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.7188
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
+1.41%
1개월 성능:
-19.85%
6개월 성능:
+23.78%
1년 성능:
-42.71%
1일 변동 폭
$4.26
$4.37
1주일 범위
$4.18
$4.37
52주 변동 폭
$1.78
$8.18
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.32 | 94.37M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
Will Adverum Biotechnologies Inc. stock deliver consistent dividendsBuy Signal & Breakout Confirmation Trade Signals - newser.com
Has Adverum Biotechnologies Inc. found a price floorSell Signal & Community Consensus Trade Alerts - newser.com
What the charts say about Adverum Biotechnologies Inc. today2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Volume spikes in Adverum Biotechnologies Inc. stock – what they meanWeekly Trade Review & Daily Profit Maximizing Tips - newser.com
Detecting price anomalies in Adverum Biotechnologies Inc. with AI2025 Price Action Summary & Safe Swing Trade Setup Alerts - newser.com
Is Adverum Biotechnologies Inc. stock poised for growthMarket Trend Review & Daily Stock Momentum Reports - newser.com
Chart overlay techniques for tracking Adverum Biotechnologies Inc.Weekly Market Summary & Weekly High Potential Stock Alerts - newser.com
Will Adverum Biotechnologies Inc. (AVU0) stock benefit from mergersInflation Watch & Verified Stock Trade Ideas - newser.com
Is Adverum Biotechnologies Inc. stock attractive for growth ETFs2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is it too late to sell Adverum Biotechnologies Inc.Portfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How rising interest rates impact Adverum Biotechnologies Inc. stockQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Real time social sentiment graph for Adverum Biotechnologies Inc.July 2025 Setups & High Yield Equity Trading Tips - newser.com
How interest rate cuts could boost Adverum Biotechnologies Inc. stockPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Eli Lilly To Acquire Adverum Biotechnologies - MSN
RBC Capital Maintains Adverum Biotechnologies (ADVM) Sector Perform Recommendation - MSN
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Mizuho Cuts Price Target on Adverum Biotechnologies to $5.50 From $12, Keeps Outperform Rating - MarketScreener
What drives Adverum Biotechnologies Inc AVU0 stock priceEarnings Revision Updates & Free Grow Wealth With Picks - earlytimes.in
Lilly to purchase Adverum Biotechnologies - Eyes On Eyecare
RBC Raises Price Target on Adverum Biotechnologies to $4 From $3, Keeps Sector Perform, Speculative Risk - MarketScreener
Adverum Biotechnologies (NASDAQ:ADVM) Stock Rating Lowered by Chardan Capital - MarketBeat
With Adverum Biotechnologies Stock Down 6.0% In A Month, How Confident Are You? - Trefis
How Adverum Biotechnologies Inc. (AVU0) stock responds to bond marketMarket Growth Report & Free Community Consensus Stock Picks - fcp.pa.gov.br
With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big (NYSE:LLY) - Seeking Alpha
Eli Lilly Taps Eyecare Market With Definitive Agreement to Acquire Adverum Biotechnologies - VisionMonday.com
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):